The respiratory distress caused by COVID-19 will likely have a severe impact on patients with ATTR amyloidosis, as amyloid fibril infiltration can be found throughout the respiratory tract at autopsy, and patients with cardiac involvement of ATTR (ATTR-CM) may have pre-existing chronic elevation of pulmonary venous pressure. The gene discussed is TTR; the disease is COVID-19.